The effects of octreotide in a patient with Nelson's syndrome

Postgrad Med J. 1996 Jan;72(843):53-4. doi: 10.1136/pgmj.72.843.53.

Abstract

We have administered octreotide, 100 micrograms tid, to a 27-year-old man with Nelson's syndrome. After seven days of therapy, adrenocorticotropin levels fell to 54% of initial values, and some shrinkage of the tumour was observed. This study indicates that octreotide therapy may have a role in the treatment of Nelson's syndrome.

Publication types

  • Comparative Study

MeSH terms

  • Adrenocorticotropic Hormone / blood
  • Adult
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Humans
  • Male
  • Nelson Syndrome / blood
  • Nelson Syndrome / drug therapy*
  • Octreotide / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Adrenocorticotropic Hormone
  • Octreotide